| CEO: | Stephen O'Hara |
| Finance Director: | David Blain |
| Non-Executive Chairman: | Neil Davidson |
| Research and Development Director: | Sofia Kolyda |
| Non-Executive Dir: | Sean Christie |
| Address: | 145-147 St John Street, London, EC1V 4PY |
| Phone: | + 44 (0) 203 178 5618 |
| Website: | http://www.optibiotix.com |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00BP0RTP38 |
| Currency | UK Pounds |
| Share Price | 9.25p |
| Change Today | 0.15p |
| % Change | 1.65 % |
| 52 Week High | 22.60 |
| 52 Week Low | 8.90 |
| Volume | 173,603 |
| Shares Issued | 103.30m |
| Market Cap | £9.56m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:01 | 5,319 @ 9.40p |
| 15:27 | 5,854 @ 9.08p |
| 15:11 | 1,357 @ 9.08p |
| 11:51 | 6,390 @ 9.28p |
| 11:09 | 7,562 @ 9.28p |
| CEO | Stephen O'Hara |
| Finance Director | David Blain |
You are here: research